Loading…
7th Promotional Review Committee Compliance & Best Practice...
Attending this event?
avatar for Eve Dryer

Eve Dryer

Retrophin
Executive Director, Patient Advocacy
During more than 25 years as a healthcare communicator, Eve has served as a patient advocacy leader, a champion for underserved populations, an innovator in patient communications, and much more. Her unwavering passion and dedication to advancing healthcare literacy and multicultural outreach and improving health outcomes in underserved communities have earned her the respect and admiration of her peers.

Eve presently serves as Executive Director for Patient Advocacy at Retrophin, working with patient communities affected by life-threatening rare diseases. She previously headed Patient Advocacy at Lexicon Pharmaceuticals for nearly four years, and, prior to that, spent 15 years as a partner in a nationally ranked healthcare communications agency, whose clients included AstraZeneca, GlaxoSmithKline and Janssen.
Under Eve’s direction, the agency earned multiple Silver Anvil Awards from the Public Relations Society of America (PRSA), including one for a multicultural campaign, Teens 4 Pink, and another for a bi-lingual national grassroots initiative to educate Seniors on the roll-out of Medicare Part D, My Medicare Matters/Mi Medicare Importa.

Prior to Vox Medica, Eve served on the senior management team of the top-ranked global Healthcare PR agency, Manning, Selvage & Lee (MSL). Eve joined MS&L from Aetna, where she had been VP for communications.

She serves on two patient advocacy boards: Sisters Network Inc., the national African American breast cancer organization, and Healing NET Foundation, which focuses on educating oncologists and patients on Neuroendocrine Tumors, a rare cancer.

Eve served three terms on the Global Board of Directors of the Healthcare Businesswomen’s Association (HBA) and was the 2013 STAR honoree, one of three individual awards presented at the annual Woman of the Year event. She was recognized as a 2008 Mover and Shaker in the annual PharmaVOICE 100, and again in 2016.